Literature DB >> 9875107

von Willebrand factor, tissue plasminogen activator, and dehydroepiandrosterone sulphate predict cardiovascular death in a 10 year follow up of survivors of acute myocardial infarction.

J H Jansson1, T K Nilsson, O Johnson.   

Abstract

BACKGROUND: Haemostasis plays a major part in the process initiating a myocardial infarction. The impact of haemostatic variables on long term prognosis is unknown.
OBJECTIVE: To evaluate von Willebrand factor (vWF), tissue plasminogen activator antigen (t-PA) and its activity before and after venous occlusion, plasminogen activator inhibitor (PAI-1), dehydroepian-drosterone sulphate (DHEAS), and established clinical risk factors as long term predictors for reinfarction and mortality. PATIENTS: 123 consecutive survivors of myocardial infarction followed up for 10 years.
DESIGN: Study entry took place between 1982 and 1983. Fifty seven patients died (54 of cardiovascular disease) during the mean observation time of 10 years.
RESULTS: Cox's univariate regression analysis showed that cardiovascular mortality was significantly associated with age, hypertension, previous history of angina pectoris, DHEAS, mass concentration of t-PA, and vWF. These associations were significant for vWF and mass concentration of t-PA after adjusting for age and hypertension.
CONCLUSIONS: A low concentration of DHEAS and high levels of the endothelially derived haemostatic variables vWF and mass concentration of t-PA are predictors of cardiovascular mortality in survivors of myocardial infarction. This association is independent of established clinical risk factors for mass concentration of t-PA and vWF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9875107      PMCID: PMC1728802          DOI: 10.1136/hrt.80.4.334

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  24 in total

1.  Anti-hypercholesterolemic effect of dehydroepiandrosterone in rats.

Authors:  M Ben-David; S Dikstein; G Bismuth; F G Sulman
Journal:  Proc Soc Exp Biol Med       Date:  1967 Aug-Sep

2.  Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study.

Authors:  T W Meade; S Mellows; M Brozovic; G J Miller; R R Chakrabarti; W R North; A P Haines; Y Stirling; J D Imeson; S G Thompson
Journal:  Lancet       Date:  1986-09-06       Impact factor: 79.321

3.  Haemostatic variables and the outcome of myocardial infarction.

Authors:  A P Haines; D Howarth; W R North; E Goldenberg; Y Stirling; T W Meade; E B Raftery; M W Millar Craig
Journal:  Thromb Haemost       Date:  1983-12-30       Impact factor: 5.249

4.  Impaired fibrinolytic capacity predisposes for recurrence of venous thrombosis.

Authors:  C Korninger; K Lechner; H Niessner; H Gössinger; M Kundi
Journal:  Thromb Haemost       Date:  1984-10-31       Impact factor: 5.249

5.  Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction.

Authors:  A Hamsten; U de Faire; G Walldius; G Dahlén; A Szamosi; C Landou; M Blombäck; B Wiman
Journal:  Lancet       Date:  1987-07-04       Impact factor: 79.321

6.  Endothelial haemostatic factors may be associated with mortality in patients on long-term anticoagulant treatment.

Authors:  M Brännström; J H Jansson; K Boman; T K Nilsson
Journal:  Thromb Haemost       Date:  1995-08       Impact factor: 5.249

7.  Relationships between tissue plasminogen activator, steroid hormones and deep vein thrombosis.

Authors:  T Nilsson; G Mellbring; J E Damber
Journal:  Acta Chir Scand       Date:  1985

8.  Therapeutic effects of dehydroepiandrosterone (DHEA) in diabetic mice.

Authors:  D L Coleman; E H Leiter; R W Schwizer
Journal:  Diabetes       Date:  1982-09       Impact factor: 9.461

9.  Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction.

Authors:  A Hamsten; B Wiman; U de Faire; M Blombäck
Journal:  N Engl J Med       Date:  1985-12-19       Impact factor: 91.245

10.  A prospective study of dehydroepiandrosterone sulfate, mortality, and cardiovascular disease.

Authors:  E Barrett-Connor; K T Khaw; S S Yen
Journal:  N Engl J Med       Date:  1986-12-11       Impact factor: 91.245

View more
  10 in total

Review 1.  Candidate-based proteomics in the search for biomarkers of cardiovascular disease.

Authors:  Leigh Anderson
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

Review 2.  Biomarkers related to aging in human populations.

Authors:  Eileen Crimmins; Sarinnapha Vasunilashorn; Jung Ki Kim; Dawn Alley
Journal:  Adv Clin Chem       Date:  2008       Impact factor: 5.394

3.  Tissue plasminogen activator antigen predicts medium-term left ventricular end-systolic volume after acute myocardial infarction.

Authors:  Robin A P Weir; Sean Balmain; Tracey Steedman; Leong L Ng; Iain B Squire; Anne Rumley; Henry J Dargie; Gordon D O Lowe
Journal:  J Thromb Thrombolysis       Date:  2010-05       Impact factor: 2.300

4.  A randomized trial of exercise for blood pressure reduction in type 2 diabetes: effect on flow-mediated dilation and circulating biomarkers of endothelial function.

Authors:  Bethany Barone Gibbs; Devon A Dobrosielski; Susanne Bonekamp; Kerry J Stewart; Jeanne M Clark
Journal:  Atherosclerosis       Date:  2012-08-02       Impact factor: 5.162

5.  Free hemoglobin increases von Willebrand factor-mediated platelet adhesion in vitro: implications for circulatory devices.

Authors:  Qi Da; Miho Teruya; Prasenjit Guchhait; Jun Teruya; John S Olson; Miguel A Cruz
Journal:  Blood       Date:  2015-08-25       Impact factor: 22.113

6.  Eight common genetic variants associated with serum DHEAS levels suggest a key role in ageing mechanisms.

Authors:  Guangju Zhai; Alexander Teumer; Lisette Stolk; John R B Perry; Liesbeth Vandenput; Andrea D Coviello; Annemarie Koster; Jordana T Bell; Shalender Bhasin; Joel Eriksson; Anna Eriksson; Florian Ernst; Luigi Ferrucci; Timothy M Frayling; Daniel Glass; Elin Grundberg; Robin Haring; Asa K Hedman; Albert Hofman; Douglas P Kiel; Heyo K Kroemer; Yongmei Liu; Kathryn L Lunetta; Marcello Maggio; Mattias Lorentzon; Massimo Mangino; David Melzer; Iva Miljkovic; Alexandra Nica; Brenda W J H Penninx; Ramachandran S Vasan; Fernando Rivadeneira; Kerrin S Small; Nicole Soranzo; André G Uitterlinden; Henry Völzke; Scott G Wilson; Li Xi; Wei Vivian Zhuang; Tamara B Harris; Joanne M Murabito; Claes Ohlsson; Anna Murray; Frank H de Jong; Tim D Spector; Henri Wallaschofski
Journal:  PLoS Genet       Date:  2011-04-14       Impact factor: 5.917

Review 7.  Prognostic Value of Dehydroepiandrosterone Sulfate for Patients With Cardiovascular Disease: A Systematic Review and Meta-Analysis.

Authors:  Ting-Ting Wu; Yuan Chen; Yun Zhou; Dilare Adi; Ying-Ying Zheng; Fen Liu; Yi-Tong Ma; Xiang Xie
Journal:  J Am Heart Assoc       Date:  2017-05-05       Impact factor: 5.501

8.  Annexin V and anti-Annexin V antibodies: two interesting aspects in acute myocardial infarction.

Authors:  Mohammad Shojaie; Abdoreza Sotoodah; Shohre Roozmeh; Ensieh Kholoosi; Samira Dana
Journal:  Thromb J       Date:  2009-07-21

9.  Abnormal hemostatic function one year after orthotopic liver transplantation can be fully attributed to endothelial cell activation.

Authors:  Freeha Arshad; Jelle Adelmeijer; Hans Blokzijl; Aad van den Berg; Robert Porte; Ton Lisman
Journal:  F1000Res       Date:  2014-05-09

10.  Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis.

Authors:  Richard G Jung; Pouya Motazedian; F Daniel Ramirez; Trevor Simard; Pietro Di Santo; Sarah Visintini; Mohammad Ali Faraz; Alisha Labinaz; Young Jung; Benjamin Hibbert
Journal:  Thromb J       Date:  2018-06-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.